Fady Ibraham Malik, EVP Research & Development at Cytokinetics, holds 138.42K shares in Cytokinetics (Ticker: CYTK), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT).

See the Hottest Stocks Based on Insider Trading >

Fady Ibraham Malik
Cytokinetics (CYTK)
EVP Research & Development

Ranked #95,442 out of 98,624 Corporate Insiders

Profitable Transactions

2 out of 9 Profitable Transactions

Average Return

-64.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

CYTK

0.00%

RCKT

A breakdown of Fady Ibraham Malik's holdings

See the Top Stocks by Insiders

Insider Roles

Cytokinetics
(CYTK)

EVP Research & Development

Rocket Pharmaceuticals
(RCKT)

Director

Roles that Fady Ibraham Malik holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Cytokinetics
(CYTK)

Rating:Informative Sell

Date:Dec 30, 2016 - Dec 30, 2017

Return:+32.90%

The most profitable trade made by Fady Ibraham Malik

See the Latest Stocks Traded by Insiders

Fady Ibraham Malik's Trading History

CYTK

Cytokinetics

Apr 15, 2024

EVP Research & Development

Uninformative Sell

―

$9.04M

RCKT

Rocket Pharmaceuticals

―

Director

―

List of latest transactions for each holding click on a transaction to see Fady Ibraham Malik's performance on stock

See All Insider Trading from Today

Fady Ibraham Malik insider profile FAQ

What is the percentage of profitable transactions made by Fady Ibraham Malik?

The percentage of profitable transactions made by Fady Ibraham Malik is 22%.

What is the average return per transaction made by Fady Ibraham Malik?

The average return per transaction made by Fady Ibraham Malik is -64.90%.

What stocks does Fady Ibraham Malik hold?

Fady Ibraham Malik holds: CYTK, RCKT stocks.

What was Fady Ibraham Malik’s latest transaction?

Fady Ibraham Malik latest transaction was an Uninformative Sell of ―.

What was Fady Ibraham Malik's most profitable transaction?

Fady Ibraham Malik’s most profitable transaction was an Informative Sell of CYTK stock on December 30, 2016. The return on the trade was 32.90%.

What is Fady Ibraham Malik's role in Cytokinetics?

Fady Ibraham Malik's role in Cytokinetics is EVP Research & Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Fady Ibraham Malik Insider Profile

Fady Ibraham Malik Cytokinetics (CYTK)EVP Research & Development